Mapfre Middlesea (MAL:MMS) Research & Development: €0.0 Mil (TTM As of Dec. 2025)


MAL:MMS Mapfre Middlesea PLC MAL:MMS
48 GF Score
Price €1.31
GF Value €1.36
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mapfre Middlesea Research & Development?

Mapfre Middlesea MAL:MMS -12.67% 48 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates MAL:MMS with a GF Score™ of 48/100 and a GF Value™ of €1.36 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mapfre Middlesea's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Mapfre Middlesea  (MAL:MMS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mapfre Middlesea Research & Development Related Terms

Mapfre Middlesea Research & Development Historical Data

* Premium members only.

The historical data trend for Mapfre Middlesea's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mapfre Middlesea Research & Development Chart

Mapfre Middlesea Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mapfre Middlesea Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MAL:MMS
48GF Score
Mapfre Middlesea PLC MAL:MMS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mapfre Middlesea Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Mapfre Middlesea (MAL:MMS) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Mapfre Middlesea and its competitors.
Is Mapfre Middlesea's Research & Development too high?
Mapfre Middlesea's current Research & Development is €0.0 Mil. Overall, Mapfre Middlesea has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mapfre Middlesea's Research & Development compare to BRK.A and AIG?
Mapfre Middlesea's Research & Development of €0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mapfre Middlesea and its competitors. Mapfre Middlesea's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mapfre Middlesea stock overvalued right now?
Based on GuruFocus' analysis, Mapfre Middlesea (MAL:MMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.36, compared to a current price of €1.31 — trading 3.7% below its estimated fair value. The current Research & Development is €0.0 Mil. Mapfre Middlesea's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mapfre Middlesea (MAL:MMS), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mapfre Middlesea (MAL:MMS) Overvalued in 2026?

Based on GuruFocus' analysis, Mapfre Middlesea stock appears to be undervalued. The current stock price of €1.31 is trading 3.7% below its estimated GF Value™ of €1.36. GuruFocus considers Mapfre Middlesea to be Fairly Valued.

Key valuation signals for MAL:MMS:

  • Research & Development: €0.0 Mil
  • GF Value™: €1.36 vs. price of €1.31 (3.7% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the MAL:MMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mapfre Middlesea Business Description

Address Middle Sea House, Floriana, MLT, FRN1442
Mapfre Middlesea PLC is an insurance company. The segments of the company are motor, Fire and other damage to property, Health, Other classes, and group life. The company provides services to individuals and businesses. The company generates the majority of its revenue from the Motor segment. The group operates only in Malta.
48GF Score

Get the complete analysis for MAL:MMS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.31
Price
€1.36
GF Value